Christine Munz appointed as CEO Wilhelm Plüster completes term in office as planned Hamburg – The Supervisory Board of Eppendorf SE has appointed Dr. Christine Munz as the new CEO of the Eppendorf Group. On October 1, 2024, she will succeed Dr. Wilhelm Plüster who will now take on other strategically relevant responsibilities in the […]

TOKYO — PHC Corporation Biomedical Division (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura, hereinafter referred to as “Biomedical Division”) will showcase a prototype of its new cell expansion system LiCellGrow at the ISCT (International Society for Cell & Gene Therapy) Europe 2024 Regional Meeting held in Gothenburg, Sweden on September 4-6. LiCellGrow, currently under development, is designed […]

Promotions expand C-suite leadership as company transitions to commercial operation and commences development of large-scale single cell product pipeline. SAN DIEGO and CAMBRIDGE, England — CS Genetics, a privately held genomics technology company, today announced the promotion of Jay Harger, PhD, to the position of Chief Operating Officer, and of Mike Stubbington, PhD, to the position of Chief Scientific Officer. In […]

Acquisition drives synergy within existing VION platform and creates greater opportunity to serve diagnostic market CHARLOTTESVILLE, Va. — VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostic, and drug discovery spaces, announces its second acquisition this August with the acquisition of Ansh Labs, a biotechnology company that […]

New software updates bring expanded capability to the ECLIPSE Ji smart imaging system MELVILLE, NY – Nikon Instruments Inc. (Nikon) is pleased to announce a new software update for the ECLIPSE Ji smart imaging system (compatible with NIS-Elements ver. 6.10 onward) that brings a variety of broadened experimental capabilities to areas such as oncology, neurology, and regenerative medicine. The […]

Tokyo, Japan. / Redwood City, CA — ThinkCyte today announced the successful completion of its Series C funding round. Including the equity financing secured last November, the company raised an additional $15 million in the extension round, bringing the total to $32 million. The extension round was led by Japan Green Investment Corp. for Carbon Neutrality […]

Under a strategic partnership with Alamar Biosciences, Biognosys is a provider of choice of NULISA multiplex assay services for biopharma research   The NULISAseq™ CNS Disease and Inflammation panels are now available for customers as a contract research service from Biognosys’ high-end proteomics facility in Europe  By offering the combination of NULISA affinity-based assays and TrueDiscovery® mass […]

Munich, DE – Biotech startup IRUBIS, developing a state-of- the – art real – time bioprocess monitoring solution, has successfully closed a pre- series A funding round. The financing round was led by BioProcess360 Partners, with participation from previous investors such as High-Tech Gründerfonds (HTGF), Verve Ventures, Ventura BioMed Investors, RoBet KG as well as […]

BC Platforms, a global leader in real world data, healthcare data management, and analytics, today announces the appointment of a new Chairperson of the Board. Jan Berger is a seasoned executive with deep experience at the intersection of healthcare, life sciences, and information technology. Under her leadership BC Platforms continues to drive growth in the global markets […]

Sensific GmbH, a German leader in advanced optical measurement and automation systems, is pleased to announce a strategic partnership with 微纳立方科技(北京)有限公司 (Microblox), a premier provider of comprehensive microfluidics laboratory solutions in China. This collaboration will see Microblox become the official distributor of Sensific’s innovative microfluidics-based products across the Chinese market. Sensific GmbH is renowned for its pioneering […]